Avenue Therapeutics, Inc. (ATXI)
OTCMKTS · Delayed Price · Currency is USD
0.3098
+0.0098 (3.27%)
May 18, 2026, 1:40 PM EST
Avenue Therapeutics Employees
Avenue Therapeutics had 1 employees as of December 31, 2025. The number of employees decreased by 1 or -50.00% compared to the previous year.
Employees
1
Change (1Y)
-1
Growth (1Y)
-50.00%
Revenue / Employee
$1,404,000
Profits / Employee
-$1,752,000
Market Cap
1.02M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1 | -1 | -50.00% |
| Dec 31, 2024 | 2 | -1 | -33.33% |
| Dec 31, 2023 | 3 | 1 | 50.00% |
| Dec 31, 2022 | 2 | -2 | -50.00% |
| Dec 31, 2021 | 4 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Emmaus Life Sciences | 33 |
| Evofem Biosciences | 29 |
| Lyra Therapeutics | 27 |
| Windtree Therapeutics | 14 |
| Eloxx Pharmaceuticals | 10 |
| CERo Therapeutics Holdings | 8 |
| Abpro Holdings | 3 |
Avenue Therapeutics News
- 3 months ago - Avenue Therapeutics enters worldwide license agreement for ATX-04 - TheFly
- 4 months ago - Avenue Therapeutics Transcript: AGM 2025 - Transcripts
- 6 months ago - Avenue Therapeutics announces Baergic Bio acquisition by Axsome - TheFly
- 1 year ago - Biotech Alert: Searches spiking for these stocks today - TheFly
- 1 year ago - Avenue Therapeutics files $35M mixed securities shelf - TheFly
- 1 year ago - Avenue Therapeutics reports Q3 EPS $(1.92) , consensus (94c) - TheFly
- 1 year ago - Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 1 year ago - Avenue Therapeutics to Participate in Maxim Group's 2024 Healthcare Virtual Summit - GlobeNewsWire